Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02885311 · ClinicalTrials.gov registry record · Phase 1
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
A Phase 1 study of Alcohol Drinking and Alcoholism, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT02885311: Completed Phase 1 study of Alcohol Drinking and Alcoholism, sponsored by Northwell Health.
NCT02885311 is a Phase 1 study of Alcohol Drinking and Alcoholism that has completed, run by Northwell Health. The registered enrollment target is 27 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02885311, a Phase 1 study of Alcohol Drinking and Alcoholism, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to develop and test a care model to treat excessive drinking and alcohol use disorders in the primary care setting. The goal of this research study is to increase the identification and treatment of problem drinking in the primary care setting. Individuals will be asked to participate in this study because routine screening and assessment conducted at your primary care clinic indicates that you have recently exceeded healthy drinking limits as outlined by the National Institutes of Alcohol and Alcoholism.
Primary Outcome
We used to the Timeline Followback Interview to collect the average weekly number of standard drinks of alcohol (about 9 grams) consumed at baseline (8 weeks prior to study enrollment) and during the 12-week treatment period. The minimum score is zero. There is no maximum score. Higher negative scores reflect a greater reduction in drinking and better outcomes.
Conditions Studied
Interventions
- DRUG Naltrexone
- BEHAVIORAL Brief Advice
- BEHAVIORAL Motivation Enhancement Therapy
- BEHAVIORAL Modified Behavioral Self-Control Therapy
- OTHER Referral to specialty substance use disorder treatment
Study Locations (1)
New York
- Northwell Health - Great Neck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-10 |
| Phase | Phase 1 |
What the finished NCT02885311 record still lists
NCT02885311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (96% lower).
The record links to 5 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 5 interventions - of which Naltrexone is the first listed.
NCT02885311 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02885311 about?
NCT02885311 is a clinical study titled "Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home". The purpose of this research study is to develop and test a care model to treat excessive drinking and alcohol use disorders in the primary care setting. The goal of this research study is to increase the identification and treatment of problem drinking in the primary care setting. Individuals will ...
What is the current status of trial NCT02885311?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2017-01. Estimated completion is 2018-10.
What conditions does trial NCT02885311 study?
This clinical trial studies the following conditions: Alcohol Drinking, Alcoholism, Alcohol Abuse, Alcohol-Related Disorders, Alcohol Use Disorders.
What interventions are being tested in trial NCT02885311?
The interventions under investigation include: Naltrexone (DRUG), Brief Advice (BEHAVIORAL), Motivation Enhancement Therapy (BEHAVIORAL), Modified Behavioral Self-Control Therapy (BEHAVIORAL), Referral to specialty substance use disorder treatment (OTHER).
Who is sponsoring clinical trial NCT02885311?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02885311 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02885311's enrollment target sits among peer trials
27 72nd of 85 higher than 14 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nicotinic Receptor Genetic Variation and Alcohol Reward
RECRUITING · Phase 1
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
-
Opioid Modulation and Neural Reward Activation in Healthy Adults
COMPLETED · Phase 1
-
A Novel Compound for Alcoholism Treatment
COMPLETED · Phase 1
-
The Behavioral Effects of Opioids and Alcohol
COMPLETED · Phase 1
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia